Table 3 Distribution and frequency of ANA staining pattern according to ICAP classification by gender, age and estimated endpoint titer.

From: Mapping of the Antinuclear Autoantibodies in Sudanese patients infected with Human Immunodeficiency Virus after HAART receiving: A cross-sectional study

Characteristics

AC-4

AC-20

AC-21

AC-16

AC-8

AC-11

AC-25

AC-7

P-value

Gender

 Male

28 (58.3%)

8(38.1%)

2(100%)

3 (100%)

3 (75%)

3(75%)

1 (50%)

1 (100%)

0.5

 Female

20(41.7%)

13(61.9%)

-

-

1 (25%)

1(25%)

1(50%)

-

Age

 ≤ 25

8 (16.7%)

4 (19%)

2 (100%)

-

-

1 (25%)

-

-

0.4

 26–41

23(47.9%)

10(47.6%)

-

2 (66.7%)

4 (100%)

1 (25%)

2 (100%)

-

 42–56

12 (25%)

6 (28.6%)

-

-

-

1 (25%)

-

1 (100%)

 ≥ 57

5 (10.4%)

1 (4.8%)

-

1 (33.3%)

-

1(25%)

-

 

Estimated endpoint titer

 1:80

36(75%)

4 (19%)

-

1 (33.3%)

-

3 (75%)

-

1(100%)

0.007

 1:160

1 (2.1%)

3 (14.3%)

-

-

-

1 (25%)

-

-

 1:320

10(20.8%)

8 (38.1%)

1(50%)

-

2 (50%)

-

2 (100%)

-

 1:640

1 (2.1%)

5 (23.8%)

1(50%)

1 (33.3%)

2 (50%)

-

-

-

 1:1280

-

1 (4.8%)

-

1 (33.3%)

-

-

-

-

Back to article page